Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$264K Sell
3,149
-13,534
-81% -$1.05M ﹤0.01% 2178
2019
Q3
$1.4M Buy
16,683
+15,221
+1,041% +$1.15M 0.01% 953
2019
Q2
$95K Buy
1,462
+230
+19% +$13.3K ﹤0.01% 2902
2019
Q1
$73K Sell
1,232
-15,429
-93% -$922K ﹤0.01% 3109
2018
Q4
$882K Sell
16,661
-4,363
-21% -$240K 0.01% 1009
2018
Q3
$1.26M Buy
21,024
+20,362
+3,076% +$1.11M 0.01% 850
2018
Q2
$29K Buy
662
+409
+162% +$16.5K ﹤0.01% 3477
2018
Q1
$9K Sell
253
-96
-28% -$3.51K ﹤0.01% 4144
2017
Q4
$12K Buy
349
+37
+12% +$1.3K ﹤0.01% 3990
2017
Q3
$10K Buy
312
+78
+33% +$2.38K ﹤0.01% 3965
2017
Q2
$7K Buy
234
+12
+5% +$337 ﹤0.01% 4096
2017
Q1
$7K Buy
+222
New +$7.17K ﹤0.01% 3971

Other funds holding MEDP

Advisor Group's MEDP Position: Q4 2019 in Review

Advisor Group reduced its Medpace (MEDP) stake by 81% in Q4 2019, selling an estimated $1.05M and leaving 3,149 shares worth $264K. The position accounts for ﹤0.01% of the portfolio, ranked #2178.

Advisor Group first reported a position in MEDP in Q1 2017 and has held it in 12 quarters since. The position peaked at $1.4M in Q3 2019. 250 funds tracked by Wall St. Rank hold MEDP as of Q4 2019.

  • Advisor Group held 3,149 shares of Medpace worth $264K as of Q4 2019.
  • Advisor Group sold 13,534 Medpace shares in Q4 2019, an estimated $1.05M.
  • Medpace made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #2178 holding.
  • Advisor Group first reported a position in Medpace in Q1 2017 and has held it in 12 quarters since.
  • Advisor Group's Medpace position peaked at $1.4M in Q3 2019.
  • 250 funds tracked by Wall St. Rank held Medpace as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.